Quick10K

⚲

Q2 Holdings

Filings

10-K	2020-12-31	Filed 2021-02-19
10-Q	2020-09-30	Filed 2020-11-05
10-Q	2020-06-30	Filed 2020-08-06
10-Q	2020-03-31	Filed 2020-05-07
10-K	2019-12-31	Filed 2020-02-21
10-Q	2019-09-30	Filed 2019-11-07
10-Q	2019-06-30	Filed 2019-08-08
10-Q	2019-03-31	Filed 2019-05-08
10-K	2018-12-31	Filed 2019-02-19
10-Q	2018-09-30	Filed 2018-11-07
10-Q	2018-06-30	Filed 2018-08-08
10-Q	2018-03-31	Filed 2018-05-03
10-K	2017-12-31	Filed 2018-02-16
10-Q	2017-09-30	Filed 2017-11-02
10-Q	2017-06-30	Filed 2017-08-03
10-Q	2017-03-31	Filed 2017-05-04
10-K	2016-12-31	Filed 2017-02-21
10-Q	2016-09-30	Filed 2016-11-03
10-Q	2016-06-30	Filed 2016-08-04
10-Q	2016-03-31	Filed 2016-05-10
10-K	2015-12-31	Filed 2016-02-12
10-Q	2015-09-30	Filed 2015-11-06
10-Q	2015-06-30	Filed 2015-08-07
10-Q	2015-03-31	Filed 2015-05-08
10-K	2014-12-31	Filed 2015-02-12
10-Q	2014-09-30	Filed 2014-11-10
10-Q	2014-06-30	Filed 2014-08-12
10-Q	2014-03-31	Filed 2014-05-14

Reports

8-K	2020-11-18
8-K	2020-11-11
8-K	2020-11-04
8-K	2020-11-02
8-K	2020-08-03
8-K	2020-07-15
8-K	2020-06-22
8-K	2020-06-09
8-K	2020-05-11
8-K	2020-05-06
8-K	2020-03-20
8-K	2020-02-19
8-K	2019-12-18
8-K	2019-11-06
8-K	2019-10-31
8-K	2019-09-30
8-K	2019-08-07
8-K	2019-07-15
8-K	2019-06-11
8-K	2019-06-06
8-K	2019-06-05
8-K	2019-05-07
8-K	2019-03-06
8-K	2019-02-13
8-K	2018-12-06
8-K	2018-11-06
8-K	2018-10-15
8-K	2018-08-07
8-K	2018-08-06
8-K	2018-06-13
8-K	2018-05-02
8-K	2018-03-08
8-K	2018-02-22
8-K	2018-02-21
8-K	2018-02-20
8-K	2018-02-14

Q2 Holdings Financials

QTWO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	87	95	72	68	94	69	75	67	55	53	52	55	43	34	40	58	258	179	214	110	112	585	603
Accounts Receivable	6	5	7	5	7	7	9	9	9	11	16	12	8	15	16	13	17	27	23	20	20	27	24
Inventory
PP&E	14	14	14	26	19	19	21	38	27	28	29	43	32	32	32	58	37	37	35	66	41	40	40
Assets	126	134	133	137	171	170	199	204	204	200	205	201	192	193	205	213	422	419	435	464	490	952	978
Accounts Payable	5	2	3	2	3	4	4	3	5	6	5	4	6	5	6	8	6	7	8	9	10	8	9
Long-Term Debt	6	2	0	0
Liabilities	51	49	52	58	62	63	75	86	92	93	103	101	91	93	103	106	267	260	275	305	338	566	596
Stockholders' Equity	75	85	81	79	109	106	123	118	112	107	102	100	100	100	103	107	155	158	160	159	152	386	382


Income Statement ($MM)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	17	19	21	22	24	26	28	30	34	36	38	42	45	48	50	52	55	59	61	67	71	82	80
Cost of Revenue	10	11	12	13	13	14	15	17	18	19	20	21	23	24	26	27	27	29	30	35	37	40	40
Gross Profit	7	8	9	9	11	12	13	14	16	17	19	21	22	23	24	25	28	29	30	32	34	38	39
R&D	3	3	3	3	4	5	6	7	8	8	8	9	10	10	10	11	11	12	13	16	18	19	20
SG&A	9	10	10	11	11	12	13	14	16	17	18	18	18	20	20	20	21	23	23	26	30	30	29
Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0	-0	0	-3	-0	-0	-0
Net Income	-6	-5	-5	-5	-5	-5	-7	-8	-10	-10	-9	-8	-7	-8	-6	-6	-6	-9	-9	-12	-19	-17	-19


Cash Flow ($MM)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	-4	0	-0	-1	-3	3	0	5	0	-3	1	5	-11	0	12	8	-7	-14	17		-11	-8	17
Cash Investing	-2	-1	-20	-4	-5	-25	-16		-11	1	-3	-3	-4	-11	-9	7	-3	-69	15		10	13	-2
Cash Financing	74	8	-2	1	34	-2	22	-1	-1	-1	1	2	3	3	3	3	207	4	3		3	467	3